Japan Intellectual Property Rights: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

Japan, Nov. 7 -- IMMATICS BIOTECHNOLOGIES GMBH has got intellectual property rights for 'NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS.' Other related details are as follows:

Application Number: JP,2021-052978

Category (FI): C12N15/12,A61K35/12,A61P35/00,A61K35/17,A61P35/02,A61K35/76,A61K48/00,A61K35/17@Z,C07K14/725,C07K7/08,C07K7/06,C12N5/0783,C12N5/10,C12N1/21,A61K38/16,C12N1/15,C12N15/115@Z,C12N15/63@Z,C07K16/30,C12P21/02@Z,A61K38/08,C12N1/19

Stage: Grant (IP right document published.)

Filing Date: March 26, 2021

Publication Date: July 26, 2021

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.